These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30094326)

  • 1. Relationship between frailty and Alzheimer's disease biomarkers: A scoping review.
    Wallace L; Theou O; Rockwood K; Andrew MK
    Alzheimers Dement (Amst); 2018; 10():394-401. PubMed ID: 30094326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do we know about frailty in the acute care setting? A scoping review.
    Theou O; Squires E; Mallery K; Lee JS; Fay S; Goldstein J; Armstrong JJ; Rockwood K
    BMC Geriatr; 2018 Jun; 18(1):139. PubMed ID: 29898673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Function and Amyloid Marker in Frail Older Adults: The COGFRAIL Cohort Study.
    Sourdet S; Soriano G; Delrieu J; Steinmeyer Z; Guyonnet S; Saint-Aubert L; Payoux P; Ousset PJ; Ghisolfi A; Chicoulaa B; Dardenne S; Gemar T; Baziard M; Guerville F; Andrieu S; Vellas B
    J Frailty Aging; 2021; 10(2):160-167. PubMed ID: 33575706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and inflammation are associated with physical frailty in patients with Alzheimer's disease.
    Namioka N; Hanyu H; Hirose D; Hatanaka H; Sato T; Shimizu S
    Geriatr Gerontol Int; 2017 Jun; 17(6):913-918. PubMed ID: 27296166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis.
    Kojima G; Liljas A; Iliffe S; Walters K
    Curr Alzheimer Res; 2017; 14(12):1256-1263. PubMed ID: 28413984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Association Between Verbal Forgetting and Pathological Markers of Alzheimer's and Lewy Body Diseases.
    Schaeffer MJ; Callahan BL;
    J Alzheimers Dis; 2019; 70(3):877-887. PubMed ID: 31282412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitioning into the caregiver role following a diagnosis of Alzheimer's disease or related dementia: A scoping review.
    Lee K; Puga F; Pickering CEZ; Masoud SS; White CL
    Int J Nurs Stud; 2019 Aug; 96():119-131. PubMed ID: 30851954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX).
    Cezar NOC; Aprahamian I; Ansai JH; de Oliveira MPB; da Silva DCP; Gomes WL; Barreiros BA; Langelli TCO; de Andrade LP
    Exp Gerontol; 2021 Jul; 150():111390. PubMed ID: 33962026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging biomarkers and screening for cognitive frailty.
    Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Lozupone M; Seripa D; Panza F; Yu Z
    Aging Clin Exp Res; 2017 Dec; 29(6):1075-1086. PubMed ID: 28260159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and frailty: A systematic review and synthesis of the best evidence.
    Soysal P; Isik AT; Carvalho AF; Fernandes BS; Solmi M; Schofield P; Veronese N; Stubbs B
    Maturitas; 2017 May; 99():66-72. PubMed ID: 28364871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty in the context of rehabilitation interventions for adults: protocol for a scoping review.
    Kokorelias KM; Munce S; McGilton KS; Cronin SM; Wang CD; Eftekhar P; Cheng DK; Vellani S; Jaglal S; Salbach NM; Kontos P; Colella TJF; Grigorovich A; Cameron JI
    BMJ Open; 2019 Feb; 9(2):e024838. PubMed ID: 30772856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.
    Forlenza OV; Diniz BS; Teixeira AL; Stella F; Gattaz W
    Braz J Psychiatry; 2013; 35(3):284-94. PubMed ID: 24142092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.
    Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Yu Z
    Mol Med Rep; 2016 Oct; 14(4):3184-98. PubMed ID: 27511317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review.
    Showraki A; Murari G; Ismail Z; Barfett JJ; Fornazzari L; Munoz DG; Schweizer TA; Fischer CE
    J Alzheimers Dis; 2019; 71(2):477-501. PubMed ID: 31424398
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.